Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
Biological Target
MCU-i4 blocks the IP3-dependent mitochondrial Ca2+-uptake, maintaining the gatekeeping role of their target.
Drug Formulation
This drug may be formulated in DMSO
Elemental Analysis
C, 73.18; H, 7.21; N, 11.13; O, 8.48
Exact Mass
377.2103
HS Tariff Code
2934.99.9001
In Vitro Activity
For this purpose, this study measured mitochondrial Ca2+ uptake speed in cells permeabilized with digitonin and then perfused with 3 μM Ca2+ in the presence of the active molecules (Figure 2C). MCU-i4 and MCU-i11 decreased mitochondrial Ca2+ uptake speed. These results confirm that the selected compounds impinge directly on the MCU complex activity rather than on Ca2+ release from intracellular stores or on cytosolic [Ca2+]. Reference: Cell Rep. 2020 Feb 18;30(7):2321-2331.e6. https://pubmed.ncbi.nlm.nih.gov/32075766/
In Vivo Activity
Both MCU-i4 and MCU-i11 inhibited mitochondrial Ca2+ uptake in myofibers (Figure 5C). Both compounds decreased myotube width (Figure 5D). These data prove the efficacy of MCU-i4 and MCU-i11 ex vivo and indicate that pharmacological modulation of mitochondrial Ca2+ uptake interferes with an essential biological process. Reference: Cell Rep. 2020 Feb 18;30(7):2321-2331.e6. https://pubmed.ncbi.nlm.nih.gov/32075766/
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Stock Solution Storage
0-4 °C for short term (days to weeks), or -20 °C for long term (months).